PRESS RELEASE published on 10/09/2025 at 17:45, 7 months 6 days ago VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap Valbiotis publishes its interim financial statements, confirms roadmap with successful commercialization, cash position of €13.2M, and growth drivers for 2026. Increased engagement with partners and all financial ambitions through 2030 affirmed Cash Position Valbiotis Commercialization Interim Financial Statements Growth Drivers
PRESS RELEASE published on 10/09/2025 at 17:45, 7 months 6 days ago VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap Valbiotis publishes interim financial results with robust commercialization timeline, solid cash position and growth drivers activated, while confirming financial ambitions through 2030. International engagements with partners intensify Financial Results Cash Position Valbiotis Growth Drivers Commercialization Timeline
PRESS RELEASE published on 10/09/2025 at 17:45, 7 months 6 days ago VALBIOTIS SA: Valbiotis publie ses comptes semestriels et confirme sa feuille de route Valbiotis publie ses comptes semestriels et confirme sa feuille de route. La société spécialisée en compléments alimentaires affiche une trésorerie solide et des ambitions financières ambitieuses pour 2027 et 2030 Valbiotis Compléments Alimentaires Trésorerie Feuille De Route Comptes Semestriels
BRIEF published on 09/01/2025 at 11:45, 8 months 15 days ago VALBIOTIS: Information on Share Capital in August 2025 Share Capital Voting Rights Actions Euronext Growth Valbiotis
BRIEF published on 09/01/2025 at 11:45, 8 months 15 days ago VALBIOTIS : Informations sur le Capital Social en Août 2025 Droits De Vote Capital Social Actions Euronext Growth Valbiotis
BRIEF published on 09/01/2025 at 11:45, 8 months 15 days ago Evolution of the share capital of Valbiotis SA Share Capital Voting Rights Euronext Growth Threshold Crossing Valbiotis SA
BRIEF published on 09/01/2025 at 11:45, 8 months 15 days ago Évolution du capital social de Valbiotis SA Droits De Vote Franchissement De Seuil Capital Social Euronext Growth Valbiotis SA
PRESS RELEASE published on 09/01/2025 at 11:40, 8 months 15 days ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social Communication mensuelle sur le nombre total de droits de vote et d'actions de Valbiotis, côté sur Euronext Growth Paris, conformément à l'article 223-16 du Règlement Général de l'AMF Euronext Growth Paris Article 223-16 Droits De Vote Capital Social Valbiotis
PRESS RELEASE published on 09/01/2025 at 11:40, 8 months 15 days ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social VALBIOTIS SA communique sur le nombre total de droits de vote et d'actions au 31/08/2025. Informations conformes \/ l'Article 223-16 du Règlement Général de l'AMF Euronext Growth Paris Droits De Vote Capital Social Valbiotis SA Information Réglementaire
BRIEF published on 08/11/2025 at 17:35, 9 months 4 days ago Mise à jour sur le capital social de Valbiotis SA Droits De Vote Franchissement De Seuil Capital Social Euronext Growth Valbiotis
Published on 05/16/2026 at 01:15, 15 hours 52 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 17 hours 7 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 17 hours 57 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 18 hours 7 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 59 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 20 hours 57 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 22 hours 57 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 1 hour ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 2 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 6 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 8 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 23 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES